Treeline Biosciences, Inc. is a privately held, clinical-stage biopharma company that aspires to create medicines at the highest level. The company matches compelling disease targets with proven drug approaches by integrating in-house R&D with leading-edge computational tools. Programs are chosen for their potential to redefine the treatment of cancer and other serious diseases. A team of biology, chemistry, protein science, computation, and clinical development leaders works across the U.S. and Europe.